Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in COPD
IRCT20251108067917N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Montelukast with Placebo (2 arms). Primary endpoints: Forced expiratory volume in 1 second and Forced vital capacity. Started Nov 2025; status: completed.
02
Drugs
montelukast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20251108067917N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251108067917N1.